相关实验视频
Updated: Jun 4, 2025

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
微氨基关联受体1 (TAAR1):神经退行性,神经发育性和神经创伤性疾病的新兴治疗点
Saher Dalvi1, Lokesh Kumar Bhatt2
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
微氨基关联受体1 (TAAR1) 调节神经传递,是神经精神疾病的点. 新兴研究突出 TAAR1 的亮点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 微氨基是内源的,生理活跃的分子,结构上与单氨基相似.
- 它们被快速代谢,导致短暂的生理可用性.
- 微氨基关联受体1 (TAAR1) 是这些氨基的关键受体,影响神经传递.
研究的目的:
- 审查TAAR1在神经系统疾病中的既定和新兴作用.
- 探索TAAR1作为神经退行性,神经发育性和神经创伤性疾病的潜在治疗点.
主要方法:
- 文献综述,重点关注TAAR1功能及其在各种神经疾病中的参与.
- 对TAAR1在神经传递和疾病病理学中的作用进行现有研究的分析.
主要成果:
- TAAR1是神经精神疾病如精神分裂症的既定目标.
- 最近的证据表明,TAAR1参与神经退行性和神经创伤性疾病的病理学.
- 在TAAR1中,TAAR1调节了谷氨基和单氨基神经传递.
结论:
- TAAR1的作用超越神经精神疾病,扩展到神经退行性,神经发育性和神经创伤性疾病.
- TAAR1代表了一种有前途的新型治疗点,用于更广泛的神经和精神疾病.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Alzheimer's Disease: Treatment
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Drugs Affecting Neurotransmitter Synthesis
Ligand-Gated Ion Channel Receptor: Gating Mechanism